|15.09||-0.6500||-4.13%||Vol 289.37K||1Y Perf -58.16%|
|May 18th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||30.33||Analyst Rating||Hold 2.67|
|Potential %||100.99||Finscreener Ranking||★★★★ 53.98|
|Insiders Trans % 3/6/12 mo.||100/100/100||Value Ranking||★★★★ 56.91|
|Insiders Value % 3/6/12 mo.||100/100/100||Growth Ranking||★★ 46.14|
|Insiders Shares Cnt. % 3/6/12 mo.||100/100/100||Income Ranking||— -|
|Price Range Ratio 52W %||3.19||Earnings Rating||Strong Sell|
|Market Cap||615.45M||Earnings Date||4th May 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.28|
|EPS Growth Next 5 Years %||8.10|
|Avg. Weekly Volume||424.76K|
|Avg. Monthly Volume||357.06K|
|Avg. Quarterly Volume||329.04K|
Cardiovascular Systems Inc. (NASDAQ: CSII) stock closed at 15.74 per share at the end of the most recent trading day (a 3.21% change compared to the prior day closing price) with a volume of 621.04K shares and market capitalization of 615.45M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 779 people. Cardiovascular Systems Inc. CEO is Scott R. Ward.
The one-year performance of Cardiovascular Systems Inc. stock is -58.16%, while year-to-date (YTD) performance is -16.19%. CSII stock has a five-year performance of -49.98%. Its 52-week range is between 14.12 and 44.57, which gives CSII stock a 52-week price range ratio of 3.19%
Cardiovascular Systems Inc. currently has a PE ratio of -19.00, a price-to-book (PB) ratio of 2.56, a price-to-sale (PS) ratio of 2.54, a price to cashflow ratio of 289.80, a PEG ratio of 2.32, a ROA of -9.98%, a ROC of -11.31% and a ROE of -12.78%. The company’s profit margin is -13.46%, its EBITDA margin is -10.40%, and its revenue ttm is $244.71 Million , which makes it $6.00 revenue per share.
Of the last four earnings reports from Cardiovascular Systems Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.28 for the next earnings report. Cardiovascular Systems Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Cardiovascular Systems Inc. is Hold (2.67), with a target price of $30.33, which is +100.99% compared to the current price. The earnings rating for Cardiovascular Systems Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Cardiovascular Systems Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Cardiovascular Systems Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 9.67, ATR14 : 1.17, CCI20 : -62.82, Chaikin Money Flow : -0.08, MACD : -1.56, Money Flow Index : 50.47, ROC : -15.83, RSI : 37.74, STOCH (14,3) : 25.12, STOCH RSI : 1.00, UO : 44.79, Williams %R : -74.88), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Cardiovascular Systems Inc. in the last 12-months were: Erik Paulsen (Buy at a value of $9 523), Jeffrey S. Points (Buy at a value of $36 400), Martha Goldberg Aronson (Buy at a value of $46 075), Rhonda J. Robb (Buy at a value of $29 326), Scott R. Ward (Buy at a value of $46 293)
Wed, 18 May 2022 09:25 GMT Cardiovascular Systems (CSII) Gets a Hold Rating from Needham- TipRanks. All rights reserved.
Thu, 05 May 2022 12:46 GMT Cardiovascular Systems (CSII) Gets a Buy Rating from SVB Securities- TipRanks. All rights reserved.
Wed, 13 Apr 2022 09:45 GMT Analysts Offer Insights on Healthcare Companies: Cardiovascular Systems (CSII) and Evofem Biosciences (EVFM)- TipRanks. All rights reserved.
Sun, 06 Feb 2022 13:38 GMT Cardiovascular Systems (CSII) Gets a Buy Rating from Leerink Partners- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.